Skip to main content
All lobbying filings

BUCHANAN INGERSOLL & ROONEY PC

Lobbying for AIM IMMUNOTECH INC. · Biopharmaceutical company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · Florida · House · Senate · $20,000.00 income · posted Jul 17, 2025

Official filing document

 Lobbying activity 2
Health Issues

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. Work with Department of Defense on Ebola countermeasures. Comprehensive Access to Resources and Education (CARE) For Long COVID Act

Pharmacy

Strategy development and implementation of company's federal government relations initiatives relating to research and development of therapeutics. Work with Department of Defense on Ebola countermeasures. Comprehensive Access to Resources and Education (CARE) For Long COVID Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem